SCHEMBL2218769

SCHEMBL2218769

CCOC(=O)c1ccc(-c2cccc(C)c2CN)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAOA P21397 1/20 0.41
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
CD274 Q9NZQ7 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
ESR1 P03372 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
ESR2 Q92731 1/20 0.39
CA14 Q9ULX7 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29800427 0.78 CA12 (0.56) CYP1A2LMNACYP3A4MAOANPC1
SCHEMBL811649 0.78 CA12 (0.56) CYP1A2LMNACYP3A4MAOANPC1
SCHEMBL28779574 0.77 MKNK1 (0.46) CYP1A2LMNACYP3A4MAOANPC1
SCHEMBL2215985 0.77 SMN1; SMN2 (0.43) CYP1A2LMNACYP3A4MAOANPC1
SCHEMBL6178023 0.75 ALDH1A1 (0.49) NPC1RAB9ASMN1; SMN2CA12CA1
SCHEMBL3159422 0.74 ALDH1A1 (0.50) CYP1A2LMNANPC1RAB9ASMN1; SMN2
SCHEMBL5964500 0.74 OXTR (0.48) CYP1A2NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL4651619 0.74 CYP1A2 (0.47) CYP1A2LMNACYP3A4MAOANPC1
SCHEMBL1222552 0.73 NPC1 (0.62) CYP1A2LMNANPC1RAB9ASMN1; SMN2
SCHEMBL7930158 0.73 LMNA (0.53) CYP1A2LMNACYP3A4MAOANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638964-B1 NOVEL COMPOUNDS THAT MODULATE PPAR-GAMMA TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2011-07-27 EP disclosed